TANI, MONICA
TANI, MONICA
Alma Mater Studiorum Universita' di Bologna
Lenalidomide plus rituximab for the initial treatment of elderly frail patients with DLBCL: the FIL_ReRi Phase 2 Study
2023 Gini, Guido; Tani, Monica; Tucci, Alessandra; Marcheselli, Luigi; Cesaretti, Marina; Bellei, Monica; Pascarella, Anna; Ballerini, Filippo; Petrini, Mauro; Merli, Francesco; Olivieri, Attilio; Lanza, Francesco; Annibali, Ombretta; Zilioli, Vittorio Ruggero; Liberati, Anna Marina; Tisi, Maria Chiara; Arcari, Annalisa; Marino, Dario; Musuraca, Gerardo; Pavone, Vincenzo; Fabbri, Alberto; Pozzi, Samantha; Mannina, Donato; Plenteda, Caterina; Celli, Melania; Luminari, Stefano
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma
2023 Lolli, Ginevra; Argnani, Lisa; Gini, Guido; Casadei, Beatrice; Pellegrini, Cinzia; Tani, Monica; Pavone, Vincenzo; Cimminiello, Michele; Bonifazi, Francesca; Zinzani, Pier Luigi
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice
2019 Broccoli, Alessandro; Casadei, Beatrice; Chiappella, Annalisa; Visco, Carlo; Tani, Monica; Cascavilla, Nicola; Conconi, Annarita; Balzarotti, Monica; Cox, Maria Christina; Marino, Dario; Goldaniga, Maria Cecilia; Marasca, Roberto; Tecchio, Cristina; Patti, Caterina; Musuraca, Gerardo; Devizzi, Liliana; Monaco, Federico; Romano, Alessandra; Fama, Angelo; Zancanella, Michelle; Paolini, Rossella; Rigacci, Luigi; Castellino, Claudia; Gaudio, Francesco; Argnani, Lisa; Zinzani, Pier Luigi
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)
2018 Stefoni, Vittorio; Pellegrini, Cinzia; Broccoli, Alessandro; Baldini, Luca; Tani, Monica; Cencini, Emanuele; Figuera, Amalia; Ansuinelli, Michela; Bernocco, Elisa; Cantonetti, Maria; Cox, Maria Christina; Ballerini, Filippo; Rusconi, Chiara; Visco, Carlo; Arcaini, Luca; Fama, Angelo; Marasca, Roberto; Volpetti, Stefano; Castellino, Alessia; Califano, Catello; Cavaliere, Marina; Gini, Guido; Liberati, Anna Marina; Musuraca, Gerardo; Lucania, Anna; Ricciuti, Giuseppina; Argnani, Lisa; Zinzani, Pier Luigi
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma
2017 Pellegrini, Cinzia; Broccoli, Alessandro; Pulsoni, Alessandro; Rigacci, Luigi; Patti, Caterina; Gini, Guido; Mannina, Donato; Tani, Monica; Rusconi, Chiara; Romano, Alessandra; Vanazzi, Anna; Botto, Barbara; Santoro, Armando; Hoaus, Stefan; Rigolin, Gian Matteo; Musto, Pellegrino; Mazza, Patrizio; Molica, Stefano; Corradini, Paolo; Fama, Angelo; Gaudio, Francesco; Merli, Michele; Ronconi, Fioravante; Gritti, Giuseppe; Vallisa, Daniele; Tosi, Patrizia; Liberati, Anna Marina; Pinto, Antonello; Pavone, Vincenzo; Gherlinzoni, Filippo; Bianchi, Maria Paola; Volpetti, Stefano; Trentin, Livio; Goldaniga, Maria Cecilia; Bonfichi, Maurizio; De Renzo, Amalia; Schiavotto, Corrado; Spina, Michele; Carella, Angelo Michele; Stefoni, Vittorio; Argnani, Lisa; Zinzani, Pier Luigi
Interim positron emission tomography response-adapted therapy in advanced-stage hodgkin lymphoma: Final results of the phase II part of the HD0801 study
2016 Zinzani, PIER LUIGI; Broccoli, Alessandro; Gioia, Daniela Maria; Castagnoli, Antonio; Ciccone, Giovannino; Evangelista, Andrea; Santoro, Armando; Ricardi, Umberto; Bonfichi, Maurizio; Brusamolino, Ercole; Rossi, Giuseppe; Anastasia, Antonella; Zaja, Francesco; Vitolo, Umberto; Pavone, Vincenzo; Pulsoni, Alessandro; Rigacci, Luigi; Gaidano, Gianluca; Stelitano, Caterina; Salvi, Flavia; Rusconi, Chiara; Tani, Monica; Freilone, Roberto; Pregno, Patrizia; Borsatti, Eugenio; Sacchetti, Gian Mauro; Argnani, Lisa; Levis, Alessandro
Safety and Efficacy of Single-Agent Bendamustine After Failure of Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin's Lymphoma: Experience With 27 Patients.
2015 P. L. Zinzani;U. Vitolo;S. Viviani;P. Corradini;G. Motta;M. Tani;N. Cascavilla;S. Hohaus;F. Merli;L. Argnani;A. Broccoli
Patologic IL 17 Producing Helper T Cells In Acute Myeloid Leukemia Patients
2013 Gerardo Musuraca, Serena De Matteis, Roberta Napolitano, Francesco Fabbri, Delia Cangini, Michela Ceccolini, Maria Benedetta Giannini, Alessandro Lucchesi, Sonia Ronconi, Cristina Papayannidis, Viviana Guadagnuolo, Giovanni Martinelli, Paolo Savini, Monica Tani, Patrizia Tosi, Dino Amadori, Pier Paolo Fattori, Wainer Zoli, Silvia Carloni
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
2012 Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M.
FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma.
2010 Lopci E; Santi I; Tani M; Maffione AM; Montini G; Castellucci P; Stefoni V; Rubello D; Fonti C; Zinzani P; Fanti S.
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma.
2009 Maffione A.M.; Castellucci P.; Stefoni V.; Nanni C.; Tani M.; Rubello D.; Ambrosini V.; Zinzani P.; Franchi R.; Fanti S.
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma
2009 Zinzani P.L.; Stefoni V.; Tani M.; Fanti S.; Musuraca G.; Castellucci P.; Marchi E.; Fina M.; Ambrosini V.; Pellegrini C.; Alinari L.; Derenzini E.; Montini G.; Broccoli A.; Bacci F.; Pileri S.; Baccarani M.
A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma
2008 Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenzini E.; Baccarani M.
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.
2008 Zinzani PL; Tani M; Fanti S; Stefoni V; Musuraca G; Castellucci P; Marchi E; Farsad M; Fina M; Pellegrini C; Alinari L; Derenzini E; de Vivo A; Bacci F; Pileri S; Baccarani M.
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET.
2008 Tsamita C.S.; Golemi A.; Egesta L.; Castellucci P.; Nanni C.; Stefoni V.; Grassetto G.; Rubello D.; Tani M.; Zinzani P.L.; Fanti S.
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET.
2008 Fanti S.; Castellucci P.; Stefoni V.; Nanni C.; Tani M.; Rubello D.; Ambrosini V.; Zinzani P.L.; Franchi R.
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
2008 Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A; Zaccaria A; Voso MT; Fattori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M.
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
2008 Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccarani M; Zinzani PL.
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231).
2007 Isidori A.; Tani M.; Bonifazi F.; Zinzani P.; Curti A.; Motta M.R.; Rizzi S.; Giudice V.; Farese O.; Rovito M.; Alinari L.; Conte R.; Baccarani M.; Lemoli R.M.
FDG-PET in the serial assessment of patinets with lymphoma in complete remission
2007 V. Ambrosini; P.L. Zinzani; P. Castellucci; V. Stefoni; C. Nanni; M. Tani; M. Farsad; L. Alinari; D. Rubello; R. Franchi; S. Fanti
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Lenalidomide plus rituximab for the initial treatment of elderly frail patients with DLBCL: the FIL_ReRi Phase 2 Study | Gini, Guido; Tani, Monica; Tucci, Alessandra; Marcheselli, Luigi; Cesaretti, Marina; Bellei, Moni...ca; Pascarella, Anna; Ballerini, Filippo; Petrini, Mauro; Merli, Francesco; Olivieri, Attilio; Lanza, Francesco; Annibali, Ombretta; Zilioli, Vittorio Ruggero; Liberati, Anna Marina; Tisi, Maria Chiara; Arcari, Annalisa; Marino, Dario; Musuraca, Gerardo; Pavone, Vincenzo; Fabbri, Alberto; Pozzi, Samantha; Mannina, Donato; Plenteda, Caterina; Celli, Melania; Luminari, Stefano | 2023-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma | Lolli, Ginevra; Argnani, Lisa; Gini, Guido; Casadei, Beatrice; Pellegrini, Cinzia; Tani, Monica; ...Pavone, Vincenzo; Cimminiello, Michele; Bonifazi, Francesca; Zinzani, Pier Luigi | 2023-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice | Broccoli, Alessandro; Casadei, Beatrice; Chiappella, Annalisa; Visco, Carlo; Tani, Monica; Cascav...illa, Nicola; Conconi, Annarita; Balzarotti, Monica; Cox, Maria Christina; Marino, Dario; Goldaniga, Maria Cecilia; Marasca, Roberto; Tecchio, Cristina; Patti, Caterina; Musuraca, Gerardo; Devizzi, Liliana; Monaco, Federico; Romano, Alessandra; Fama, Angelo; Zancanella, Michelle; Paolini, Rossella; Rigacci, Luigi; Castellino, Claudia; Gaudio, Francesco; Argnani, Lisa; Zinzani, Pier Luigi | 2019-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
| Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study) | Stefoni, Vittorio; Pellegrini, Cinzia; Broccoli, Alessandro; Baldini, Luca; Tani, Monica; Cencini..., Emanuele; Figuera, Amalia; Ansuinelli, Michela; Bernocco, Elisa; Cantonetti, Maria; Cox, Maria Christina; Ballerini, Filippo; Rusconi, Chiara; Visco, Carlo; Arcaini, Luca; Fama, Angelo; Marasca, Roberto; Volpetti, Stefano; Castellino, Alessia; Califano, Catello; Cavaliere, Marina; Gini, Guido; Liberati, Anna Marina; Musuraca, Gerardo; Lucania, Anna; Ricciuti, Giuseppina; Argnani, Lisa; Zinzani, Pier Luigi | 2018-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
| Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma | Pellegrini, Cinzia; Broccoli, Alessandro; Pulsoni, Alessandro; Rigacci, Luigi; Patti, Caterina; G...ini, Guido; Mannina, Donato; Tani, Monica; Rusconi, Chiara; Romano, Alessandra; Vanazzi, Anna; Botto, Barbara; Santoro, Armando; Hoaus, Stefan; Rigolin, Gian Matteo; Musto, Pellegrino; Mazza, Patrizio; Molica, Stefano; Corradini, Paolo; Fama, Angelo; Gaudio, Francesco; Merli, Michele; Ronconi, Fioravante; Gritti, Giuseppe; Vallisa, Daniele; Tosi, Patrizia; Liberati, Anna Marina; Pinto, Antonello; Pavone, Vincenzo; Gherlinzoni, Filippo; Bianchi, Maria Paola; Volpetti, Stefano; Trentin, Livio; Goldaniga, Maria Cecilia; Bonfichi, Maurizio; De Renzo, Amalia; Schiavotto, Corrado; Spina, Michele; Carella, Angelo Michele; Stefoni, Vittorio; Argnani, Lisa; Zinzani, Pier Luigi | 2017-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Interim positron emission tomography response-adapted therapy in advanced-stage hodgkin lymphoma: Final results of the phase II part of the HD0801 study | Zinzani, PIER LUIGI; Broccoli, Alessandro; Gioia, Daniela Maria; Castagnoli, Antonio; Ciccone, Gi...ovannino; Evangelista, Andrea; Santoro, Armando; Ricardi, Umberto; Bonfichi, Maurizio; Brusamolino, Ercole; Rossi, Giuseppe; Anastasia, Antonella; Zaja, Francesco; Vitolo, Umberto; Pavone, Vincenzo; Pulsoni, Alessandro; Rigacci, Luigi; Gaidano, Gianluca; Stelitano, Caterina; Salvi, Flavia; Rusconi, Chiara; Tani, Monica; Freilone, Roberto; Pregno, Patrizia; Borsatti, Eugenio; Sacchetti, Gian Mauro; Argnani, Lisa; Levis, Alessandro | 2016-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Safety and Efficacy of Single-Agent Bendamustine After Failure of Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin's Lymphoma: Experience With 27 Patients. | P. L. Zinzani;U. Vitolo;S. Viviani;P. Corradini;G. Motta;M. Tani;N. Cascavilla;S. Hohaus;F. Merli...;L. Argnani;A. Broccoli | 2015-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Patologic IL 17 Producing Helper T Cells In Acute Myeloid Leukemia Patients | Gerardo Musuraca, Serena De Matteis, Roberta Napolitano, Francesco Fabbri, Delia Cangini, Michela... Ceccolini, Maria Benedetta Giannini, Alessandro Lucchesi, Sonia Ronconi, Cristina Papayannidis, Viviana Guadagnuolo, Giovanni Martinelli, Paolo Savini, Monica Tani, Patrizia Tosi, Dino Amadori, Pier Paolo Fattori, Wainer Zoli, Silvia Carloni | 2013-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; P...ellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. | 2012-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma. | Lopci E; Santi I; Tani M; Maffione AM; Montini G; Castellucci P; Stefoni V; Rubello D; Fonti C; Z...inzani P; Fanti S. | 2010-01-01 | THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. | Maffione A.M.; Castellucci P.; Stefoni V.; Nanni C.; Tani M.; Rubello D.; Ambrosini V.; Zinzani P....; Franchi R.; Fanti S. | 2009-01-01 | CLINICAL NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma | Zinzani P.L.; Stefoni V.; Tani M.; Fanti S.; Musuraca G.; Castellucci P.; Marchi E.; Fina M.; Amb...rosini V.; Pellegrini C.; Alinari L.; Derenzini E.; Montini G.; Broccoli A.; Bacci F.; Pileri S.; Baccarani M. | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma | Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenz...ini E.; Baccarani M. | 2008-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. | Zinzani PL; Tani M; Fanti S; Stefoni V; Musuraca G; Castellucci P; Marchi E; Farsad M; Fina M; Pe...llegrini C; Alinari L; Derenzini E; de Vivo A; Bacci F; Pileri S; Baccarani M. | 2008-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. | Tsamita C.S.; Golemi A.; Egesta L.; Castellucci P.; Nanni C.; Stefoni V.; Grassetto G.; Rubello D....; Tani M.; Zinzani P.L.; Fanti S. | 2008-01-01 | NUCLEAR MEDICINE COMMUNICATIONS | - | 1.01 Articolo in rivista | - |
| Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. | Fanti S.; Castellucci P.; Stefoni V.; Nanni C.; Tani M.; Rubello D.; Ambrosini V.; Zinzani P.L.; ...Franchi R. | 2008-01-01 | ANNALS OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ). |
Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A; Zaccaria A; Voso MT; Fat...tori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M. |
2008-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma. | Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccaran...i M; Zinzani PL. | 2008-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). | Isidori A.; Tani M.; Bonifazi F.; Zinzani P.; Curti A.; Motta M.R.; Rizzi S.; Giudice V.; Farese ...O.; Rovito M.; Alinari L.; Conte R.; Baccarani M.; Lemoli R.M. | 2007-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| FDG-PET in the serial assessment of patinets with lymphoma in complete remission | V. Ambrosini; P.L. Zinzani; P. Castellucci; V. Stefoni; C. Nanni; M. Tani; M. Farsad; L. Alinari;... D. Rubello; R. Franchi; S. Fanti | 2007-01-01 | - | Society of Nuclear Medicine | 4.02 Riassunto (Abstract) | - |